BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 8877939)

  • 1. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection.
    La Civita L; Zignego AL; Lombardini F; Monti M; Longombardo G; Pasero G; Ferri C
    J Rheumatol; 1996 Sep; 23(9):1641-3. PubMed ID: 8877939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment].
    Lidove O; Cacoub P; Hausfater P; Wechsler B; Frances C; Leger JM; Piette JC
    Gastroenterol Clin Biol; 1999 Mar; 23(3):403-6. PubMed ID: 10384347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy during interferon-alpha therapy in patients with cryoglobulinemia and hepatitis virus infection.
    Zuber M; Gause A
    J Rheumatol; 1997 Dec; 24(12):2488-9. PubMed ID: 9415668
    [No Abstract]   [Full Text] [Related]  

  • 4. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
    Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD
    J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection.
    Paoletti V; Donnarumma L; De Matteis A; Mammarella A; Labbadia G; Musca A; Francia A
    Panminerva Med; 2000 Sep; 42(3):175-8. PubMed ID: 11218620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.
    Zuckerman E; Keren D; Slobodin G; Rosner I; Rozenbaum M; Toubi E; Sabo E; Tsykounov I; Naschitz JE; Yeshurun D
    J Rheumatol; 2000 Sep; 27(9):2172-8. PubMed ID: 10990230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peripheral neuropathy involving cranial nerves in a patient with hepatitis C virus infection and mixed cryoglobulinemia].
    Nagakane Y; Ijichi T; Akiyama K; Mori S; Shimamura O; Nakajima K
    Rinsho Shinkeigaku; 2000 Jun; 40(6):591-5. PubMed ID: 11086399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.
    Cai FZ; Ahern M; Smith M
    J Rheumatol; 2006 Jun; 33(6):1197-8. PubMed ID: 16755669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of cyroglobulinemia and polyneuropathy in a chronic myeloid leukemia patient during interferon-alpha treatment].
    Uoshima N; Akaogi T; Hayashi H; Kobayashi Y; Kondo M
    Rinsho Ketsueki; 1999 Apr; 40(4):324-9. PubMed ID: 10355142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity.
    Cid MC; Hernández-Rodríguez J; Robert J; del Río A; Casademont J; Coll-Vinent B; Grau JM; Kleinman HK; Urbano-Márquez A; Cardellach F
    Arthritis Rheum; 1999 May; 42(5):1051-5. PubMed ID: 10323463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study.
    Caniatti LM; Tugnoli V; Eleopra R; Tralli G; Bassi R; De Grandis D
    J Peripher Nerv Syst; 1996; 1(2):131-8. PubMed ID: 10975721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extrahepatic manifestations of HBV and HCV infection].
    Hartmann H
    Praxis (Bern 1994); 1997 Jul; 86(29-30):1163-6. PubMed ID: 9333915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis.
    Lo KY; Chen CY; Lee CS
    Ren Fail; 2009; 31(2):149-52. PubMed ID: 19212913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed cryoglobulinemia and hepatitis C virus infection.
    Lunel F; Musset L
    Minerva Med; 2001 Feb; 92(1):35-42. PubMed ID: 11317137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
    Lunel F; Cacoub P
    Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cryoglobulinemia related to the hepatitis B and C viruses].
    Cohen P
    Pathol Biol (Paris); 1999 Mar; 47(3):232-6. PubMed ID: 10214614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia].
    Lidove O; Maisonobe T; Servan J; Thibault V; Léger JM; Piette JC; Cacoub P
    Rev Med Interne; 2001 Oct; 22(10):939-47. PubMed ID: 11695317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.